Speeding Up the Discovery of Drugs

An entrepreneur with MS pushes a new research model
One out of every 5,000 to 10,000 potential treatments discovered in the lab makes it to market Illustration by 731; Pills: Dwight Eschliman/Getty Images

When Scott Johnson read an article about a potential breakthrough that restored nerve function in mice with multiple sclerosis, he assumed it would soon be turned into a treatment. That was in 2001. Johnson, who was diagnosed with MS at age 20 in 1976, is still waiting.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.